CVRdatabase
Menu

Imprint Medicine ApS

Private limited companyCVR 45469964København NActive

Imprint Medicine ApS is a private limited company, based in København N, active in research and experimental development on natural sciences and engineering, founded in 2025. Equity was negative at the end of 2026 (−DKK 1.9m). The company is new and has been registered for 1 years. The latest net result (2026) was a loss of DKK 2m.

Follow
PDF reportCompare

Key figures · financial year 2026

Gross profit−DKK 926k
Net profit−DKK 2m
Equity−DKK 1.9m
Employees4latest month from CVR

What has changed

calculated from recorded figures and dates

Management and owners, last 24 months

  • New in management: Peter Ahn Mouritzen (director, 06/03/2025), Emil Christian Fischer (director, 06/03/2025) and Faizaan Mohammad (director, 06/03/2025).
  • New owners registered: Ahn Capital ApS (06/03/2025), ECF Holding ApS (06/03/2025) and Shams ApS (06/03/2025) (+3).
  • No longer registered as owner: Peter Ahn Mouritzen (06/03/2025), Emil Christian Fischer (06/03/2025) and Faizaan Mohammad (06/03/2025).

Registrations, last 24 months

  • 08/09/2025: Moved to Ole Maaløes Vej 3, 2200 København N

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2026–2026 · amounts in DKK thousand
Financial figures for Imprint Medicine ApS
2026Change
Revenuenot stated–
Gross profit−926–
Profit before tax−2,516–
Net profit−1,963–
Total assets2,495–
Equity−1,942–
Liabilities4,437–
Cash and cash equivalents1,841–
Average number of employees3–

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2026: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

Signals from the financial statements

calculated from the 2026 figures

  • Negative equity

    Equity was −DKK 1.9m at the end of 2026.

    How is this calculated?

    Equity in the latest annual report is below zero.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

1 financial years
Annual reports for Imprint Medicine ApS
Financial yearPeriodPublishedFigures forDocuments
202606/03/2025 – 31/03/202601/07/2026The companyPDF not statedXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0123409/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profit−DKK 926kNo. 326 of 421
Better than 23% of the companies in the industry
Equity−DKK 1.9mNo. 357 of 431
Better than 17% of the companies in the industry
Number of employees4No. 254 of 431
Better than 41% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bn
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 68,699of 69,742
Better than 1%
No. 68,199of 69,964
Better than 3%
Same industry and fewer than 20 employees329 companies in the comparison
No. 248of 323
Better than 23%
No. 267of 329
Better than 19%
Companies that are founded within the last five years16,662 companies in the comparison
No. 16,273of 16,614
Better than 2%
No. 16,205of 16,661
Better than 3%
All companies of type ApS66,508 companies in the comparison
No. 65,571of 66,379
Better than 1%
No. 64,733of 66,505
Better than 3%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Imprint Medicine ApS−DKK 926k
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Imprint Medicine ApS−DKK 2m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Imprint Medicine ApS−DKK 1.9m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Imprint Medicine ApS4
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Ahn Capital ApS33.33%
  • ECF Holding ApS33.33%
  • Shams ApS33.33%
Imprint Medicine ApS

Management

3 active registrations

Executive management

Executive management at Imprint Medicine ApS
NameRoleAppointed
Peter Ahn MouritzenDirector06/03/2025
Emil Christian FischerDirector06/03/2025
Faizaan MohammadDirector06/03/2025
Founders
Ahn Capital ApS, ECF Holding ApS, Shams ApS

Signing rule: Selskabet tegnes af 2 direktører i forening.

Address and production units

1 active production units

Ole Maaløes Vej 3
2200 København N

København Municipality · Postcode 2200

Other companies at the address (8)

  • BII Holdings A/SOther financial service activities n.e.c.
  • Skape Bio ApSResearch and experimental development on natural sciences and engineering
  • Agrobiomics ApSResearch and experimental development on natural sciences and engineering
  • Tetrakit Technologies ApSResearch and experimental development on natural sciences and engineering
  • BioColor ApSResearch and experimental development on natural sciences and engineering
Production units
Production unitAddressEmployeesP number
Imprint Medicine ApSOle Maaløes Vej 3, 2200 København N41031160959

Purpose

Selskabets formål er at udføre aktiviteter relaterede til forskning og udvikling rettet mod bioteknologi, og udvikling og kommercialisering af lægemidler, samt andre lægemiddel-udvikling relaterede aktiviteter.

The purpose is quoted from the register in Danish.

Changes year by year

15 registered events
20261 changeaccounts 1
  • Annual report for 2026 published
202514 changesaddress 1 · founded 1 · management 3 · ownership 9
  • Moved to Ole Maaløes Vej 3, 2200 København N
  • Registered as Imprint Medicine ApS
  • Peter Ahn Mouritzen appointed director
  • Emil Christian Fischer appointed director
  • Faizaan Mohammad appointed director
  • Peter Ahn Mouritzen registered as owner (100%)
  • Peter Ahn Mouritzen is no longer registered as owner
  • Emil Christian Fischer registered as owner (100%)
  • Emil Christian Fischer is no longer registered as owner
  • Faizaan Mohammad registered as owner (100%)
  • Faizaan Mohammad is no longer registered as owner
  • Ahn Capital ApS registered as owner (33.33%)
  • ECF Holding ApS registered as owner (33.33%)
  • Shams ApS registered as owner (33.33%)

Related companies

Same industry in København

See all →

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction